Congestion and Sinonasal Illness in Outer Space: A Study on the International Space Station
Laryngoscope Investigative Otolaryngology · 2025-08 · 10 (4)
DOI: 10.1002/lio2.70229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngoscope Investigative Otolaryngology, online erschienen am 05.08.2025. Verfasst von Faizaan Khan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Texas A&M School of Engineering Medicine Houston Texas USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
This study aims to characterize quantitative data pertaining to sinonasal symptoms and their related medication use aboard the International Space Station (ISS). A secondary focus involves correlating these findings with mission parameters such as extravehicular activity (EVA) participation and mission duration.
Methods
This retrospective cohort study was conducted utilizing data requested from the National Aeronautics and Space Administration (NASA) Lifetime Surveillance of Astronaut Health (LSAH) program.
Results
Of 71 de‐identified ISS astronauts beginning with Expedition 1 in the year 2000 through 62 in 2019, there were 754 logged medical events; 60 astronauts reported any type of sinonasal medical event (85%), the most common being general nasal congestion in 53 astronauts (75%). Symptoms were attributed to microgravity‐induced fluid shifts in 34 astronauts (57%) while 17 (28%) attributed symptoms to ear clearing and barotrauma. Pseudoephedrine was the most used medication, with 95 recorded uses, followed by oxymetazoline spray at 51. Among the 60 astronauts with sinonasal medical events, the 24 with references to extravehicular activity (EVA) participation in their records had on average, 9.19 more records than those without (95% CI: 2.29–17.06).
Conclusion
Sinonasal symptoms are a prevalent medical concern among astronauts aboard the ISS. The findings suggest that early spaceflight‐associated fluid shifts contribute significantly to these symptoms, often requiring medication use. A correlation between EVA participation and a higher number of medical events highlights an occupational risk factor. Level of Evidence 3.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Texas A&M School of Engineering Medicine Houston Texas USA.
- Department of Otolaryngology - Head and Neck Surgery Houston Methodist Hospital Houston Texas USA.
- Center for Space Medicine Baylor College of Medicine Houston Texas USA.
ORCID-Profile: Faizaan Khan, Zain Mehdi, Aatin K Dhanda, Samuel E Razmi
Zitieren
APA
Khan, F., Ansingkar, K., Dongre, R., Mehdi, Z., Dhanda, A. K., Powell, K., Syed, T., Razmi, S. E., Somawardana, I., Vrabec, J. T., Hilmers, D., Ahmed, O. G., & Takashima, M. (2025). Congestion and Sinonasal Illness in Outer Space: A Study on the International Space Station. Laryngoscope Investigative Otolaryngology, 10(4). https://doi.org/10.1002/lio2.70229
Vancouver
Khan F, Ansingkar K, Dongre R, Mehdi Z, Dhanda AK, Powell K, et al. Congestion and Sinonasal Illness in Outer Space: A Study on the International Space Station. Laryngoscope Investigative Otolaryngology. 2025;10(4). doi:10.1002/lio2.70229
BibTeX
@article{Khan2025,
author = {Khan, Faizaan and Ansingkar, Koyal and Dongre, Roshan and Mehdi, Zain and Dhanda, Aatin K and Powell, Kayla and Syed, Tariq and Razmi, Samuel E and Somawardana, Isuru and Vrabec, Jeffrey T and Hilmers, David and Ahmed, Omar G and Takashima, Masayoshi},
title = {Congestion and Sinonasal Illness in Outer Space: A Study on the International Space Station},
journal = {Laryngoscope Investigative Otolaryngology},
year = {2025},
volume = {10},
number = {4},
doi = {10.1002/lio2.70229}
}
EUVIMED